Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $260.44M≈ (-$12M≈)
- Previous value:
- $272.61M≈
- # of changes:
- 30
- New positions:
- 1
- Reported for:
- 30 Sep 2021 (Q3)
- Latest filing date:
- 10 Dec 2021
Muhlenkamp & Co has disclosed a total of 30 changes to the portfolio in the (2021 Q3) SEC report(s): bought 1 totally new, decreased the number of shares of 27 and completely sold out 2 position(s).
What stocks did Ronald Muhlenkamp buy in 2021 Q3?
During 2021 Q3 Ronald Muhlenkamp has bought (EQC) Equity Commonwealth (new buy).
What did Ronald Muhlenkamp invest in during 2021 Q3?
In the 2021 Q3 report(s) the following changes have been made to the top investments: (WCC) WESCO International Inc (reduced shares -0.17%), (MCHP) Microchip Technology Inc (reduced shares -0.19%), (MCK) McKesson Corp (reduced shares -0.13%) and (BFH) Bread Financial Holdings, Inc (reduced shares -0.17%).
30 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Equity Commonwealth
|
new
|
+112,943
|
112,943
|
+1.13%
|
$25.98
|
|
1.13%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
McKesson Corp
|
-0.13%
|
-83
|
65,548
|
-0.01%
|
$199.38
|
+327.02%($851.39)
|
5.02%
|
2016 Q2
|
≈ 5.00 years
|
|
|
|
Royal Gold Inc
|
-0.14%
|
-33
|
24,350
|
-0%
|
$95.48
|
+109.66%($200.19)
|
0.89%
|
2020 Q4
|
≈ 1.00 year
|
|
|
|
Franco-Nevada Corp
|
-0.14%
|
-29
|
20,853
|
-0%
|
$129.91
|
+64.83%($214.13)
|
1.04%
|
2020 Q4
|
≈ 1.00 year
|
|
|
|
Westinghouse Air Brake Technologies Corp
|
-0.15%
|
-82
|
55,276
|
-0%
|
$86.20
|
+242.66%($295.39)
|
1.83%
|
2019 Q1
|
≈ 2.50 years
|
|
|
|
Lockheed Martin Corp
|
-0.16%
|
-30
|
19,319
|
-0%
|
$345.10
|
+68.42%($581.22)
|
2.56%
|
2019 Q3
|
≈ 2.00 years
|
|
|
|
Berkshire Hathaway Inc
|
-0.16%
|
-58
|
36,975
|
-0.01%
|
$272.94
|
+87.73%($512.40)
|
3.87%
|
2019 Q3
|
≈ 2.00 years
|
|
|
|
Alerian MLP ETF
|
-0.16%
|
-451
|
280,436
|
-0.01%
|
$33.33
|
+64.54%($54.84)
|
3.59%
|
2018 Q1
|
≈ 3.25 years
|
|
|
|
Bristol-Myers Squibb Company
|
-0.16%
|
-204
|
125,419
|
-0%
|
$59.17
|
+9.63%($64.86)
|
2.85%
|
2019 Q4
|
≈ 1.75 years
|
|
|
|
TENNECO INC, CL-A
|
-0.17%
|
-952
|
575,419
|
-0%
|
$14.27
|
|
3.15%
|
2019 Q4
|
≈ 1.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.